secwatch.observer — SEC 8-K summary
======================================

Issuer:     SOLESENCE, INC. (SLSN)
CIK:        0000883107
Form:       8-K
Filed at:   2023-03-29T23:59:59+00:00
Accession:  0001171843-23-001979
Event type: earnings
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nanophase reports record FY2022 revenue $37.3M (+27% YoY) but net loss of $2.6M
-------------------------------------------------------------------------------

- FY2022 revenue $37.3M, up 27% YoY; Q4 revenue $8.3M, up 12% YoY.
- Net loss $2.6M ($0.05/sh) vs net income $2.3M ($0.05/sh) in 2021.
- Solésence revenue $23.1M (+27%); Personal Care Ingredients $11.1M (+44%); Advanced Materials $3.1M (-14%).
- Atypical expenses $1.6M: $0.7M cyber theft loss, $0.4M litigation legal fees, $0.3M bad debt.
- Received US patent allowance for Kleair skin health tech; named No.2 in Fast Company Beauty innovation list.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/883107/000117184323001979/0001171843-23-001979-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/883107/000117184323001979/f8k_032923.htm
  HTML page:      https://secwatch.observer/filing/0001171843-23-001979

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer